Potential antitumor agents. Part 29(1): synthesis and potential coanthracyclinic activity of imidazo[2,1-b]thiazole guanylhydrazones. 2000

A Andreani, and A Leoni, and A Locatelli, and R Morigi, and M Rambaldi, and M Recanatini, and V Garaliene
Dipartimento di Scienze Farmaceutiche, Università di Bologna, Italy. aldoandr@alma.unibo.it

This paper reports the synthesis of new imidazo[2,1-b]thiazole guanylhydrazones which were tested as potential antitumor agents. Three of these derivatives (those bearing a 3- or 4-nitrophenyl group) were the most potent and one of these showed a mild effect as CDK1 inhibitor. These same three derivatives were also tested as positive inotropic agents and two of them were more potent than amrinone at 10(-5) M. These two guanylhydrazones could be useful coanthracyclinic agents.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D010210 Papillary Muscles Conical muscular projections from the walls of the cardiac ventricles, attached to the cusps of the atrioventricular valves by the chordae tendineae. Muscle, Papillary,Muscles, Papillary,Papillary Muscle
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006835 Hydrazones Compounds of the general formula R:N.NR2, as resulting from the action of hydrazines with aldehydes or ketones. (Grant & Hackh's Chemical Dictionary, 5th ed) Hydrazone
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

A Andreani, and A Leoni, and A Locatelli, and R Morigi, and M Rambaldi, and M Recanatini, and V Garaliene
November 1992, Journal of medicinal chemistry,
A Andreani, and A Leoni, and A Locatelli, and R Morigi, and M Rambaldi, and M Recanatini, and V Garaliene
January 1994, In vivo (Athens, Greece),
A Andreani, and A Leoni, and A Locatelli, and R Morigi, and M Rambaldi, and M Recanatini, and V Garaliene
January 1993, Journal de pharmacie de Belgique,
A Andreani, and A Leoni, and A Locatelli, and R Morigi, and M Rambaldi, and M Recanatini, and V Garaliene
January 2022, Medicinal chemistry (Shariqah (United Arab Emirates)),
A Andreani, and A Leoni, and A Locatelli, and R Morigi, and M Rambaldi, and M Recanatini, and V Garaliene
August 2022, RSC advances,
A Andreani, and A Leoni, and A Locatelli, and R Morigi, and M Rambaldi, and M Recanatini, and V Garaliene
January 1992, Farmaco (Societa chimica italiana : 1989),
A Andreani, and A Leoni, and A Locatelli, and R Morigi, and M Rambaldi, and M Recanatini, and V Garaliene
January 1983, Archiv der Pharmazie,
A Andreani, and A Leoni, and A Locatelli, and R Morigi, and M Rambaldi, and M Recanatini, and V Garaliene
December 2014, ChemMedChem,
A Andreani, and A Leoni, and A Locatelli, and R Morigi, and M Rambaldi, and M Recanatini, and V Garaliene
January 2017, European journal of medicinal chemistry,
A Andreani, and A Leoni, and A Locatelli, and R Morigi, and M Rambaldi, and M Recanatini, and V Garaliene
February 2010, European journal of medicinal chemistry,
Copied contents to your clipboard!